TNFRSF1B and sarcoidosis: Interestingly, in sarcoidosis the percentage of CD4+TNFR2+ cells is increased, especially in patients in remission or with stable disease (respectively 35% and 33%), which may indicate a role in down regulation of a cell-mediated immune response [23].